These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17459415)

  • 1. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R
    J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.
    Hohlfeld R; Kerschensteiner M; Stadelmann C; Lassmann H; Wekerle H
    Neurol Sci; 2006 Mar; 27 Suppl 1():S1-7. PubMed ID: 16708174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases.
    Kerschensteiner M; Stadelmann C; Dechant G; Wekerle H; Hohlfeld R
    Ann Neurol; 2003 Mar; 53(3):292-304. PubMed ID: 12601697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.
    Hohlfeld R; Kerschensteiner M; Stadelmann C; Lassmann H; Wekerle H
    J Neuroimmunol; 2000 Jul; 107(2):161-6. PubMed ID: 10854651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA
    Neurology; 2007 May; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helminth infections associated with multiple sclerosis induce regulatory B cells.
    Correale J; Farez M; Razzitte G
    Ann Neurol; 2008 Aug; 64(2):187-99. PubMed ID: 18655096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis.
    Schulz KH; Gold SM; Witte J; Bartsch K; Lang UE; Hellweg R; Reer R; Braumann KM; Heesen C
    J Neurol Sci; 2004 Oct; 225(1-2):11-8. PubMed ID: 15465080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects of repair in multiple sclerosis.
    Yong VW
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S16-8. PubMed ID: 19200859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of multiple sclerosis.
    Agrawal SM; Yong VW
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
    Weinstock-Guttman B; Zivadinov R; Tamaño-Blanco M; Abdelrahman N; Badgett D; Durfee J; Hussein S; Feichter J; Patrick K; Benedict R; Ramanathan M
    J Neuroimmunol; 2007 Aug; 188(1-2):167-74. PubMed ID: 17602759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Ziemssen T; Schrempf W
    Int Rev Neurobiol; 2007; 79():537-70. PubMed ID: 17531858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment.
    Antel J
    Clin Neurol Neurosurg; 2006 Mar; 108(3):245-9. PubMed ID: 16384636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between the immune and central nervous systems in neuronal injury.
    Yong VW; Marks S
    Neurology; 2010 Jan; 74 Suppl 1():S9-S16. PubMed ID: 20038767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology of multiple sclerosis].
    Laplaud DA; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1306-12. PubMed ID: 16948218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Schrempf W; Ziemssen T
    Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system.
    Raab S; Plate KH
    Acta Neuropathol; 2007 Jun; 113(6):607-26. PubMed ID: 17492293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapy.
    Vaknin-Dembinsky A; Weiner HL
    J Neurol Sci; 2007 Aug; 259(1-2):90-4. PubMed ID: 17521671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.